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OBJECTIVES We sought to study the relationships between chemokines and oxidative stress in acute
coronary syndrome.
BACKGROUND In view of existing knowledge on the participation of leukocytes and oxidative stress in the
pathogenesis of acute coronary syndrome, we hypothesized that chemokines may play a role
in recruiting and activating leukocytes in this disorder.
METHODS The levels of chemokines and oxidative stress were studied in 38 patients with stable and 38
with unstable angina and in 20 controls. In separate in vitro experiments the effect of
chemokines on reactive oxygen species in monocytes and the effect of antioxidants on
chemokine levels in these cells were also studied.
RESULTS 1) Angina patients had raised serum levels of chemokines in both cross-sectional and
longitudinal testing, with particularly high levels of interleukin (IL)-8, monocyte chemoat-
tractant protein (MCP)-1 and macrophage inflammatory peptide (MIP)-1-alpha in unstable
disease. 2) T cells, and particularly monocytes, seem to contribute to the raised IL-8, MCP-1
and MIP-1-alpha levels in unstable angina. 3) Concomitantly, and significantly correlated
with MCP-1 and IL-8 levels, stable and particularly unstable angina patients had decreased
plasma levels of antioxidants and increased lipid peroxidation, suggesting enhanced oxidative
stress. 4) Monocyte chemoattractant protein-1 enhanced the generation of O2
2 in monocytes
from unstable angina patients, and the antioxidant glutathione-monoethyl ester suppressed
the production of IL-8 and MCP-1 in these cells.
CONCLUSIONS Our findings suggest an interaction between chemokines and oxidative stress in unstable
angina. This interaction may represent a vicious circle involved in the pathogenesis of acute
coronary syndromes. (J Am Coll Cardiol 2001;37:485–91) © 2001 by the American College
of Cardiology
Increasing evidence supports the involvement of inflamma-
tion in atherogenesis and in the pathogenesis of acute
coronary syndrome. Thus, activated monocytes, T cells and
granulocytes have been demonstrated in patients with un-
stable angina (1,2), and extensive infiltration of blood-
derived macrophages and T cells into the vessel wall is seen
in the active stages of atherosclerosis (3). Chemokines are a
family of inflammatory cytokines characterized by their
ability to cause directed migration of leukocytes, and raised
levels are found in several inflammatory disorders (4). There
is also some evidence suggesting that chemokines, e.g.,
interleukin (IL)-8 and monocyte chemoattractant protein 1
(MCP-1), may play a role in the pathogenesis of athero-
sclerosis (5,6). In addition to being potent chemoattractants,
several other leukocyte responses such as enzyme secretion
and induction of reactive oxygen species (ROS) have been
observed in vitro after chemokine stimulation (4,7). Some of
these responses may clearly be relevant to the development
of coronary artery disease (CAD). In particular, enhanced
oxidative stress has been implicated in the pathogenesis of
CAD and in the triggering of unstable angina (8). In view
of the existing knowledge on the association of leukocyte
activation and oxidative stress with atherosclerosis and acute
coronary syndrome, we hypothesized that chemokines may
play an important role in recruiting and activating leuko-
cytes and in enhancing oxidative stress in these disorders. In
the present study we investigated this hypothesis by differ-
ent experimental approaches in stable and unstable angina
patients.
METHODS
Patients and controls. Between January and June 1998
patients undergoing diagnostic coronary angiography in the
coronary care unit at our hospital were consecutively regis-
tered. Among those fulfilling the criteria of unstable angina
(see following text), 38 patients were selected randomly for
participation in the study (Table 1). All patients with
unstable angina had experienced ischemic chest pain at rest
within the proceeding 48 h, with no evidence of myocardial
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necrosis by enzymatic criteria. Transient ST-T segment
depression and/or T-wave inversion were present in all
cases. For comparison, 38 patients with stable angina were
randomly selected among those attending the Department
of Cardiology at our hospital in the same period for
diagnostic coronary angiography (Table 1). All these pa-
tients had stable effort angina of .6 months duration and a
positive exercise test. Exclusion criteria included myocardial
infarction within the previous month, ECG abnormalities
invalidating ST-segment analyses, thrombolytic therapy the
previous month, body temperature .38.0°C or the occur-
rence of inflammatory disease likely to be associated with
acute-phase response (e.g., infections, malignancies or
autoimmune disorders). Controls in the study were 20
gender- and age-matched healthy blood donors (15 males
and five females, age 53 6 15 years). Blood collection and
isolation of monocytes and T (CD31) cells for the study was
performed as previously described (9,10). Informed consent
for participation in the study was obtained from all individ-
uals.
Superoxide anion (O2
2) assay. Monocytes (3 3 105/ml;
200 ml/well) were cultured in 96-well trays (Costar, Cam-
bridge, Massachusetts) in RPMI 1640 with L-glutamine
(Gibco, Paisley, United Kingdom) supplemented with 10%
fetal calf serum (Myoclone, Gibco) either alone or with
different concentrations of MCP-1, IL-8 or macrophage
inflammatory peptide 1-alpha (MIP-1-alpha), all from
R&D Systems, Minneapolis, Minnesota. After 20 h, O2
2
generation in monocytes was measured by the superoxide
dismutase-inhibitable reduction of cytochrome c as previ-
ously described (10).
Chemokine production in vitro. CD31T cells (106cells/
ml) and monocytes (3 3 105cells/ml) were incubated in
96-well trays (200 ml/well, Costar) in medium alone (RPMI
1640 with 2 mmol/l L-glutamine and 25 mmol/L HEPES
buffer; Gibco, supplemented with 10% fetal calf serum) or
with stimulants: CD31 T cells: anti-CD3 monoclonal
antibodies (final concentration 1.2 ng/ml; clone SpvT3b) (9)
combined with anti-CD28 monoclonal antibodies (final
concentration 50 ng/ml; clone 15E8 (402); CLB, Amster-
dam, Netherlands) and cross-linking immunomagnetic
beads (9); monocytes: lipopolysaccharide (LPS) from E. coli
O26:B6 (final concentration 10 ng/ml, Sigma). In some
experiments different concentrations of glutathione-
monoethyl ester (Bachem, Bubendorf, Switzerland) were
added to cultures before stimulation. Cell-free supernatants
were harvested after 48 h and stored at 280°C.
Measurements of chemokines. Levels of RANTES,
MCP-1, MIP-1-alpha, IL-8, ENA-78 and GRO-alpha
were determined by enzyme immunoassays (R&D Sys-
tems).
Abbreviations and Acronyms
CAD 5 coronary artery disease
ENA-78 5 epithelial neutrophil-activating
peptide-78
GRO-alpha 5 growth-regulated oncogene alpha
IL-8 5 interleukin-8
LPS 5 lipopolysaccharide
MCP-1 5 monocyte chemoattractant protein 1
MIP-1-alpha 5 macrophage inflammatory peptide
1-alpha
O2
2 5 superoxide anion
RANTES 5 regulated on activation normally T cell
expressed and secreted
ROS 5 reactive oxygen species
Table 1. Characteristics of the Study Group
Stable
Angina
(n 5 38)
Unstable
Angina
(n 5 38) p Value
Age (yrs) 59 6 11 58 6 12 0.600
Gender (males/females) 31/7 29/9 0.576
Smokers (%) 21 47 0.030
Medication (%)
Calcium antagonist 15 22 0.422
Aspirin 91 89 0.752
HMG CoA reductase inhibitors 74 53 0.075
Beta blockers 88 97 0.147
Long-acting nitrates 41 50 0.462
Infusion of nitroglycerin 0 17 0.013
Warfarin 12 14 0.792
Numbers of affected coronary
arteries (%)
0.132
1 44 31
2 35 26
3 21 43
Total cholesterol (mmol/l) 4.8 6 0.9 4.9 6 1.0 0.870
HDL cholesterol (mmol/l) 1.1 6 0.3 0.9 6 0.3 0.031
Triglycerides (mmol/l) 1.8 6 1.1 1.8 6 0.9 0.927
Data are given as mean 6 SD.
HDL 5 high density lipoprotein; HMG CoA 5 hepatic hydroxymethylglutaryl coenzyme A.
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Parameters of oxidative stress and vitamin levels in
plasma. Concentrations of vitamin C, vitamin E and beta-
carotene were measured by high-performance liquid chro-
matography (11). Total (free and esterified) 8-isoprostane
(8-iso Prostaglandin F2a) in plasma were analyzed by
enzyme immunoassay (Cayman Chemical, Ann Arbor,
Michigan). Sample purification and recovery analyses were
performed according to the purification protocol provided
by the manufacturer.
Statistical analysis. When comparing three groups, one-
way ANOVA was followed by Scheffe’s post hoc test for
statistical significance. The chemokine data were not nor-
mally distributed and were subjected to logarithmic trans-
formation before the ANOVA analysis was performed. For
comparisons within the same individuals over time, the
Wilcoxon matched pairs test was used. P-values are consid-
ered significant when ,0.05.
RESULTS
Serum levels of chemokines in angina patients. Levels of
all measured chemokines were elevated in both unstable and
stable angina patients comparing healthy controls (Fig. 1).
Although there were no significant differences in RANTES,
ENA-78 or GRO-alpha levels between stable and unstable
angina, particularly high IL-8, MCP-1 and MIP-1-alpha
levels were found in unstable disease (Fig. 1). In ten patients
with unstable angina, blood samples were also available
before the patients developed an unstable disease (median
time between blood samplings: 12 [range 4 to 20] weeks).
Concomitant with the progression from stable to unstable
angina, there was a significant rise in IL-8, MCP-1 and
MIP-1-alpha (p , 0.005), but not in levels of the other
three chemokines (data not shown).
Release of chemokines from monocytes and T cells in
peripheral blood. To possibly define the cellular sources of
IL-8, MCP-1 and MIP-1-alpha in unstable angina, spon-
taneous and stimulated release of these chemokines from T
cells and monocytes were measured in five patients with
stable angina, five with unstable angina and five controls.
Monocytes in unstable angina released increased levels of
IL-8, MIP-1-alpha and MCP-1 both spontaneously and
after LPS stimulation, comparing cells in stable angina
patients (p , 0.05) and controls (p , 0.01). Furthermore,
anti-CD3/anti-CD28 stimulated T cells from patients with
unstable disease released higher levels of MIP-1-alpha
comparing the two other groups of individuals (p , 0.05).
Chemokine levels in relation to oxidative stress. We first
analyzed plasma levels of 8-isoprostane, a sensitive marker
of lipid peroxidation (12), and the antioxidant vitamins
beta-carotene, vitamin C and vitamin E in 40 angina
patients (20 with stable and 20 with unstable disease) and
ten controls. Angina patients had raised 8-isoprostane
concentrations compared with controls, with particularly
high levels in unstable disease (Fig. 2). Furthermore, vita-
min C, vitamin E and beta-carotene levels in unstable
angina were significantly decreased compared with both
stable angina patients and controls (Fig. 2). In unstable
angina, IL-8 and MCP-1 were positively correlated with
8-isoprostane (r 5 0.71, p , 0.001; r 5 0.65, p , 0.005)
and negatively correlated with vitamin E (r 5 20.61, p ,
0.01; r 5 20.69, p , 0.001) and beta-carotene levels (r 5
20.57, p , 0.01; r 5 20.50, p , 0.05), IL-8 and MCP-1,
respectively.
The effect of chemokines on oxidative stress and vice
versa. By additional experiments we further examined the
relationship between oxidative stress and chemokines in seven
patients with stable angina, seven with unstable angina and
seven controls. Several significant findings were revealed. First,
spontaneous and zymosan-stimulated O2
2generation was
markedly enhanced in monocytes from unstable, but not from
stable angina patients, compared with controls (Fig. 3). Sec-
ond, MCP-1, but not IL-8 or MIP-1-alpha, markedly en-
hanced zymosan-stimulated O2
2generation in monocytes
from both patients and controls, with particularly enhancing
effect in those with unstable disease, when added to cell
cultures at the start of the culture period (Fig. 3A). Finally,
MCP-1, but not IL-8 or MIP-1-alpha, also directly induced
O2
2generation in a dose-dependent manner in both patients
and controls, with particularly enhancing effect in unstable
angina, when added to monocytes after 20 h of culture in
medium alone (Fig. 4C).
When the antioxidant glutathione-monoethyl ester was
added to monocyte cultures, there was a dose-dependent
reduction in LPS-stimulated release of IL-8 and MCP-1,
but not MIP-1-alpha, in both patients and controls, with a
particularly suppressive effect in unstable angina (Fig. 4A
and B). In stable and particularly in unstable angina such a
reduction was also found in the spontaneous release of these
chemokines (Fig. 4C and D). Glutathione-monoethyl ester
also suppressed MCP-1, but not MIP-1-alpha levels, in
stimulated T cells in both patients and controls (data not
shown).
DISCUSSION
The present study shows that raised levels of several che-
mokines characterize angina patients, particularly those with
unstable disease. Concomitantly, and significantly corre-
lated with raised MCP-1 and IL-8 levels, stable and
particularly unstable angina patients had decreased plasma
levels of antioxidants and increased lipid peroxidation,
suggesting enhanced oxidative stress in these patients.
Finally, MCP-1 was found to enhance ROS generation in
monocytes from unstable angina patients and the antioxi-
dant glutathione-monoethyl ester reduced the production of
IL-8 and MCP-1 in these cells, suggesting an interaction
between chemokines and oxidative stress in unstable angina.
Enhanced levels of CXC- and CC-chemokines in unsta-
ble angina. We demonstrate that angina patients have
raised levels of both CC and CXC-chemokines with par-
ticularly high IL-8, MCP-1 and MIP-1-alpha levels in
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unstable disease, possibly reflecting pathogenic processes in
these patients. Migration of monocytes into the arterial wall
is an early event in atheroma formation, and chemokines
may be involved in this process (5). Thus, the selective
absence of the MCP-1 receptor CCR2 decreases athero-
sclerosis formation in apolipoprotein E null mice (13).
Moreover, infiltration and activation of circulating T cells
and monocytes into the atherosclerotic lesion may also be
involved in the triggering of acute coronary syndromes (3).
Again, chemokines may play an important role in this
immune-mediated plaque destabilization, not only by re-
cruiting activated leukocytes into the plaque (5), but also by
directly contributing to plaque rupture and thrombus for-
mation (14,15). We found that monocytes and T cells in
unstable angina released increased levels of chemokines. If
such activation also exists within the atheroma, our findings
may represent pathogenic processes involved in the trigger-
ing of acute coronary syndromes.
Figure 1. Serum levels of IL-8 (A), MIP-1-alpha (B), MCP-1 (C), GRO-alpha (D), ENA-78 (E) and RANTES (F) in 38 patients with unstable angina
pectoris (AP), 38 patients with stable AP and 20 healthy controls. Horizontal lines represent median values.
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MCP-1 enhances ROS generation from monocytes in
unstable angina. We found markedly decreased levels of
several antioxidants in angina patients, with particularly low
levels in unstable disease. This decrease in unstable angina was
accompanied by increased lipid peroxidation and enhanced
ROS generation in monocytes, suggesting enhanced oxidative
stress in these patients. Although several factors may mediate
enhanced ROS generation in unstable angina (e.g., oxidized
LDL, hypoxia/reoxygenation) (8), our results suggest that
chemokines and particularly MCP-1 may be involved. Several
cytokines may prime phagocytes for enhanced ROS generation
(9), but only certain chemokines may directly induce ROS
Figure 2. Plasma levels of 8-isoprostane (A), beta-carotene (B), vitamin C (C) and vitamin E (D) in 20 patients with unstable angina pectoris (AP), 20
patients with stable AP and 10 healthy controls. Horizontal lines represent median values.
Figure 3. MCP-1 and production of reactive oxygen species in monocytes from seven patients with unstable angina pectoris (AP), seven patients with stable
AP and seven healthy controls. (A) The effect of different concentrations of MCP-1 on zymosan-stimulated O2
2 generation when added to cell cultures
at the start of the culture period (20 hours before zymosan stimulation). (B) The effect of different concentrations of MCP-1 on O2
2 generation when added
to monocytes after 20 h of culture in medium alone. *p , 0.05 and **p , 0.01 versus no addition of MCP-1. Data are given as mean 6 SEM. Note: both
unstimulated and zymosan-stimulated O2
2 generation after 20 h of culture in medium alone (MCP-1 5 0 ng/ml) were significantly raised in unstable
angina patients comparing both those with stable disease and healthy controls (p , 0.01).
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generation as demonstrated for MCP-1 in the present study,
with particularly enhancing effects in monocytes in unstable
angina.
Antioxidants impair the release of chemokines from
monocytes in unstable angina. Whereas MCP-1 en-
hanced ROS generation in monocytes from unstable angina
patients, glutathione-monoethyl ester markedly suppressed
MCP-1 and IL-8 production in these cells. Several studies
have demonstrated that oxidative stress may activate the
transcription factor NF-kappa-B in various cell types (16).
Notably, NF-kappa-B, which recently was found to be
activated in leukocytes from unstable angina patients (17), is
involved in the induction of IL-8 and MCP-1 in both T
cells and monocytes (18,19). Thus, if similar mechanisms
also operate in vivo within an atherosclerotic lesion, the
interaction between chemokines and oxidative stress may
represent a pathogenic loop in unstable angina.
Interaction between chemokines and oxidative stress—
possible pathogenic role in plaque rupture. Unstable
angina patients had raised levels of chemokines and oxida-
tive stress compared with stable angina patients, and as for
spontaneous and MCP-1 induced O2
2 production, there
was no overlap between the two patient groups. These
findings may be of interest. Thus, enhanced ROS genera-
tion within the atherosclerotic plaque may promote apopto-
sis and enhance the activity of matrix degrading enzymes
within the atherosclerotic lesion, potentially promoting
plaque destabilization (20). Also, although moderately
raised chemokine levels may play a role in the development
of stable angina, more marked chemokine activation in
patients with a pre-existing atherosclerotic plaque, particu-
larly when combined with enhanced oxidative stress, may
contribute to the promotion of plaque rupture.
Conclusions. The interaction between chemokines and
oxidative stress in angina patients may represent pathogenic
mechanisms. Though it may not necessarily be the initial
event, this “pathogenic loop” may contribute to the progres-
sion of atherosclerosis in these patients. Even more impor-
tantly, this vicious circle seems to be particularly activated in
unstable disease, and such interaction between chemokines
and oxidation may represent pathogenic processes involved
in the triggering of acute coronary syndromes.
Reprint requests and correspondence: Dr. Pål Aukrust, Section of
Clinical Immunology and Infectious Diseases, Medical Department,
Rikshospitalet, Sognsvannsveien 20, N-0027 Oslo, Norway. E-mail:
pal.aukrust@rikshospitalet.
Figure 4. The effect of different concentrations of glutathione-monoethyl ester on the release of MCP-1 (A and C) and IL-8 (B and D) in LPS-stimulated
(A and B) and unstimulated (C and D) monocytes from seven patients with unstable angina pectoris (AP), seven patients with stable AP and seven healthy
controls. Cells were cultured for 48 h. *p , 0.05 and **p , 0.01 versus no addition of glutathione-monoethyl ester.
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